Back to Journals » Degenerative Neurological and Neuromuscular Disease » Volume 7 » default

Degenerative Neurological and Neuromuscular Disease


Archive: Volume 7, 2017

Erythrocyte membrane in the evaluation of neurodegenerative disorders

Sadanand A, Janardhanan A, Sankaradoss A, Vanisree AJ, Arulnambi T, Bhanu K

Degenerative Neurological and Neuromuscular Disease 2017, 7:127-134

Published Date: 17 October 2017

Current concepts in multiple sclerosis therapy

Sedal L, Winkel A, Laing J, Law LY, McDonald E

Degenerative Neurological and Neuromuscular Disease 2017, 7:109-125

Published Date: 28 September 2017

Effects of a multimodal intervention on gait and balance of subjects with progressive multiple sclerosis: a prospective longitudinal pilot study

Bisht B, Darling WG, White EC, White KA, Shivapour ET, Zimmerman MB, Wahls TL

Degenerative Neurological and Neuromuscular Disease 2017, 7:79-93

Published Date: 26 June 2017

Characteristics of tongue and pharyngeal pressure in patients with neuromuscular diseases

Umemoto G, Furuya H, Tsuboi Y, Fujioka S, Arahata H, Sugahara M, Sakai M

Degenerative Neurological and Neuromuscular Disease 2017, 7:71-78

Published Date: 30 May 2017

Advances in the treatment of relapsing–remitting multiple sclerosis: the role of pegylated interferon β-1a

Furber KL, Van Agten M, Evans C, Haddadi A, Doucette JR, Nazarali AJ

Degenerative Neurological and Neuromuscular Disease 2017, 7:47-60

Published Date: 24 March 2017

Biomarkers of multiple sclerosis: current findings

Harris VK, Tuddenham JF, Sadiq SA

Degenerative Neurological and Neuromuscular Disease 2017, 7:19-29

Published Date: 12 January 2017